Clinical trial of mRNA universal influenza vaccine candidate begins

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known asA clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known as » The FINANCIAL Health&Beauty

Related Keywords

United States ,North Carolina ,Hugh Auchincloss ,Duke University In Durham ,National Institutes Of Health ,Collaborative Influenza Vaccine Innovation Centers Civics ,Duke Human Vaccine Institute ,Vaccine Research Center ,National Institute Of Allergy ,Centers For Disease ,National Institute ,Infectious Disease ,National Institutes ,Duke University ,Disease Control ,Health Amp Beauty ,